Skip to Main Content

Paper Details

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains.
Nat Commun
83
2022
Author NameAffiliation
Scott A HandleyWashington University School of Medicine
Yoshihiro KawaokaInfluenza Research Institute, University of Wisconsin-Madison
Yoshihiro KawaokaInstitute of Medical Science, University of Tokyo
Yoshihiro KawaokaThe Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute
James E CroweVanderbilt University Medical Center
James E CroweVanderbilt University Medical Center
James E CroweVanderbilt University Medical Center
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondWashington University School of Medicine
Michael S DiamondAndrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine
Michael S DiamondCenter for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine
  • 1 - 12

Datasets

Release 1.2